ATS 2024 Final Program

Click on the session title to view the speakers

214

MONDAY • MAY 20

1024 Engaging Government Stakeholders Increases Applied Impact of Epidemiology Research: Assessing Respiratory Health Impacts of Ambient Pollution in Rio, Brazil 1025 Air Pollution Education: A Novel Curriculum for Pulmonary and Critical Care Fellows

908 Xpert MTB/RIF Ultra Platform Enables Highly Sensitive Detection of Mycobacterium Tuberculosis in Blood 909 Omadacycline in the Treatment of Mycobacterial Pulmonary Infections: A Single-center Retrospective Review 910 Role of Linezolid in the Intensive Phase of Tuberculous Meningitis 911 Analysis of Clinical Features and Treatment Results of Elderly Tuberculosis Patients at a Tertiary Hospital in Korea 912 Characteristics and Pattern of Post-tuberculosis Lung Disease at Saint Paul Hospital Chest Clinic, Addis Ababa, Ethiopia 913 Impact of Pyrazinamide Usage on Serious Adverse Events in Elderly Tuberculosis 914 Words Matter: Use of the Word “Tuberculosis” (TB) in Chest Imaging 915 Comparative Diagnostic Accuracy of Xpert MTB/RIF and Geno Type Mtbdrplus Line Probe Assay for Tuberculous Pleural Effusion Diagnosis 916 Past Pulmonary Tuberculosis as a Risk Factor of Chronic Obstructive Pulmonary Disease Among Non-smokers: A Single Center Study 917 Prevalence and Pattern of Diagnostic Tests Utilized to Detect Latent Tuberculosis Infection in Asian Nations; A Systematic Review and Meta-analysis 918 Stigma in People With Multidrug-resistant Tuberculosis and HIV in South Africa 919 Clinical Manifestation and Treatment of Subclinical Tuberculosis in the Elderly Population: A Descriptive Study in China 920 Environmental Determinants of Lung Development in Healthy Children With and Without Tuberculosis (TB) Infection in Vietnam 921 Latent Class Analysis of Structural Factors Reveals Subgroups With Differential Adherence to Bedaquiline and Antiretroviral Therapy Among People Living With HIV and Drug Resistant Tuberculosis 922 Use of MRI Scoring for Evaluation of Treatment Outcomes in Spinal Tuberculosis

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

B106 TUBERCULOSIS BREAKTHROUGHS 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 33A-C (Upper Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 901 Driving Resolution of Tuberculosis: Ifn- g Induced Plasticity in Human Alveolar Macrophages Can Be Resolved With IL-10: Implications for Macrophage Plasticity as a Therapeutic Target for Tuberculosis 902 Longitudinal Evaluation of Lung Function From the Start to the End of Tuberculosis Treatment Among a Nigerian Cohort 903 Telacebec’s Contribution to Combination Drug Regimens Is Strain-Dependent in a Mouse Model of Tuberculosis 904 Proteolytic Products of Infection (PPI) - A New Class of Proteoform Markers in Exhaled Breath for the Noninvasive Diagnosis of Lower Respiratory Tract Infections 905 Meclizine Induces Aerobic Glycolysis in Human Macrophages and Can Enhance the Glycolytic Response to Mycobacterium Tuberculosis Infection 906 Towards Developing Steroids as Host-directed Mycobacterium Tuberculosis Infected Human Alveolar Macrophages but Improves Bacillary Killing 907 Immune Check Point Inhibitors in TB Patients: Impact on In-vitro Bacillary Clearance Therapy for Tuberculosis Pneumonia: Dexamethasone Reduces Glycolysis in

ATS 2024 Conference Program • San Diego, CA